Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.6.0.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Dec. 31, 2016
Mar. 31, 2016
Current assets    
Cash $ 628,615 $ 2,123,737
Accounts receivable 0 199,471
Prepaid expenses and other current assets 32,440 53,294
Total current assets 661,055 2,376,502
Property and equipment, net 19,508 36,038
Patents and patents pending, net 87,287 94,161
Deposits 21,747 22,415
Total assets 789,597 2,529,116
Current liabilties    
Accounts payable 292,208 244,804
Due to related parties 58,362 145,112
Other current liabilities 23,546 136,695
Total current liabilities 374,116 526,611
Convertible notes payable, net 414,398 500,139
Total liabilities 788,514 1,026,750
Commitments and Contingencies (Note 13)
EQUITY    
Common stock, par value $0.001 per share; 30,000,000 shares authorized as of December 31, 2016 and March 31, 2016; 7,783,815 and 7,622,393 shares issued and outstanding as of December 31, 2016 and March 31, 2016, respectively 7,783 7,621
Additional paid-in capital 92,159,118 88,047,142
Accumulated deficit (92,092,376) (86,502,043)
Total Aethlon Medical Inc. stockholders' equity before noncontrolling interests 74,525 1,552,720
Noncontrolling interests (73,442) (50,354)
Total equity 1,083 1,502,366
Total liabilities and equity $ 789,597 $ 2,529,116